Titan Environmental Solutions Inc. Announces Agreement to Purchase Standard Waste Services, LLC
January 16, 2024 08:00 ET
|
Titan Environmental Solutions Inc.
Troy, MI, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Titan Environmental Solutions Inc. ("Titan" or the "Company") (OTCQB: TESI) announced today that the Company signed a Membership Interest Purchase...
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
December 18, 2023 07:30 ET
|
POINT Biopharma
BEDFORD, Mass. and INDIANAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus) (NASDAQ: LNTH) and POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT) today announced...
Avricore Health Corporate Update – Company Demonstrates Strong Growth
November 30, 2023 12:58 ET
|
Avricore Health Inc.
Avricore Health provides a corporate update and results for the first 9 months of 2023.
Moxies announces the reopening of its revitalized Langley location
October 06, 2023 09:00 ET
|
Moxies
LANGLEY, British Columbia, Oct. 06, 2023 (GLOBE NEWSWIRE) -- MOXIES is delighted to announce the re-opening of its refurbished location at 8828 - 201 Street, Langley Twp. Elevating the dining...
HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion
August 08, 2023 11:54 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller...
POINT Biopharma and AdvanCell to Collaborate in the Development of Lead-212-Labeled Radioligands
June 26, 2023 07:45 ET
|
POINT Biopharma
INDIANAPOLIS and SYDNEY, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and...
Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
June 21, 2023 18:38 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and...
POINT Biopharma Announces FRONTIER Trial-in-Progress Poster Presentation at ASCO
May 25, 2023 08:30 ET
|
POINT Biopharma
PNT2004 program’s phase 1 FRONTIER trial design to be presented Abstract to be released today at 5:00 PM ET, May 25th Poster to be available starting at 9:00 AM ET, June 3rd INDIANAPOLIS, May 25,...
POINT Biopharma Makes Strategic Investment in Commercial-Scale Alpha-Emitting Isotope Manufacturer
May 15, 2023 07:35 ET
|
POINT Biopharma
INDIANAPOLIS and LANSING, Mich., May 15, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global...
Avricore Health Corporate Updates on Audited Results for 2022
May 02, 2023 07:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, May 02, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today is pleased to announce its audited final results for 2022. ...